Lumida
/DNTH
⌘K
Dianthus Therapeutics Inc

Dianthus Therapeutics Inc

DNTH
$106.20USD+2.83%+2.92 today

MARKET CAP

5.9B

P/E (TTM)

FWD P/E

DAY RANGE

$105 – $110

52W RANGE

$32
$118

AI Summary

Stalk
Sell NowMedium

DNTH is in Stage 3 distribution with price below its 50-day SMA and short EMAs, consistent with the active Bearish Pivot Point pattern signaling structural repair lower. The medium-term bias is bearish, and short-term execution readiness is confirmed by price extension and rejection below the 9/20 EMAs. Executing Sell Now into rallies back toward the 9/20 EMA and 50-day SMA resistance aligns with the prevailing downward momentum and pattern implications.

  • DNTH312 bifunctional fusion protein targets complex autoimmune disorders, IP through 2047.
  • Reached 52-week high at $114.60 with average target of $124.27.
  • Q2 2026 net loss of $50.22M with zero revenue, cash burn ongoing.
Full analysis →

Buying

5

institutions

Selling

10

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY4.12 M401.99 M+948.12 K+50.8%0.01%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

BUY3.89 M379.05 M+2.60 M+249.6%0.25%
CA

Citadel Advisors LLC

Q2 2026

SELL1.03 M100.01 M+-623.07 K-27.7%0.01%
FC

Farallon Capital Management LLC

Q1 2026

BUYNEW836.00 K70.16 M+836.00 K+0.0%0.00%
WP

Woodline Partners LP

Q2 2026

SELL500.55 K48.79 M+-366.37 K-32.9%0.15%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL162.00 K15.79 M+-312.08 K-60.3%0.02%
MM

Millennium Management LLC

Q2 2026

SELL91.84 K8.95 M+-170.12 K-59.3%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL31.78 K3.21 M+-155.00+26.5%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY33.00 K2.77 M+24.60 K+699.8%0.00%
FA

Fisher Asset Management, LLC

Q2 2026

BUY23.35 K2.28 M+10.73 K+115.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL18.20 K1.77 M+-1.23 K+8.8%0.01%
AC

Aqr Capital Management LLC

Q2 2026

SELL2.97 K289.91 K+-1.14 K-16.1%0.00%
RC

Ra Capital Management, L.P.

Q2 2026

SELL0.000.00+-2.61 M-100.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-643.60 K-100.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-55.00 K-100.0%0.00%